Literature DB >> 31760096

Towards standardization of immune functional assays.

William Mouton1, Chloé Albert-Vega2, Mathilde Boccard3, François Bartolo4, Guy Oriol2, Jonathan Lopez5, Alexandre Pachot6, Julien Textoris7, François Mallet8, Karen Brengel-Pesce2, Sophie Trouillet-Assant9.   

Abstract

Recent advances in the immunotherapy field require evaluation of the immune function to adapt therapeutic decisions. Immune functional assays (IFA) are able to reveal the immune status and would be useful to further adapt and/or improve patient's care. However, standardized methods are needed to implement IFA in clinical settings. We carried out an independent validation of a published method used to characterize the underlying host response to infectious conditions using an IFA. We evaluated the reproducibility and robustness of this IFA and the associated readout using an independent healthy volunteers (HV) cohort. Expression of a 44-gene signature and IFNγ protein secretion was assessed after stimulation. We observed a strong host-response correlation between the two cohorts. We also highlight that standardized methods for immune function evaluation exist and could be implemented in larger-scale studies. This IFA could be a relevant tool to reveal innate and adaptive immune dysfunction in immune-related disorders patients.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Host response; Immune functional assay; Independent validation; Standardization; Stimulation

Mesh:

Substances:

Year:  2019        PMID: 31760096     DOI: 10.1016/j.clim.2019.108312

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

1.  Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.

Authors:  Andrés Pizzorno; Blandine Padey; Thomas Julien; Sophie Trouillet-Assant; Aurélien Traversier; Elisabeth Errazuriz-Cerda; Julien Fouret; Julia Dubois; Alexandre Gaymard; François-Xavier Lescure; Victoria Dulière; Pauline Brun; Samuel Constant; Julien Poissy; Bruno Lina; Yazdan Yazdanpanah; Olivier Terrier; Manuel Rosa-Calatrava
Journal:  Cell Rep Med       Date:  2020-07-21

Review 2.  Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage.

Authors:  James Isaacs; Aaron C Tan; Brent A Hanks; Xiaofei Wang; Kouros Owzar; James E Herndon; Scott J Antonia; Steven Piantadosi; Mustafa Khasraw
Journal:  Clin Cancer Res       Date:  2021-07-26       Impact factor: 12.531

Review 3.  Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review.

Authors:  Benjamin M Liu; Thomas B Martins; Lisa K Peterson; Harry R Hill
Journal:  Cytokine       Date:  2021-02-23       Impact factor: 3.926

4.  Deciphering heterogeneity of septic shock patients using immune functional assays: a proof of concept study.

Authors:  Chloé Albert Vega; Guy Oriol; François Bartolo; Jonathan Lopez; Alexandre Pachot; Thomas Rimmelé; Fabienne Venet; Véronique Leray; Guillaume Monneret; Benjamin Delwarde; Karen Brengel-Pesce; Julien Textoris; François Mallet; Sophie Trouillet-Assant
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

5.  Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review.

Authors:  Omid Rezahosseini; Dina Leth Møller; Andreas Dehlbæk Knudsen; Søren Schwartz Sørensen; Michael Perch; Finn Gustafsson; Allan Rasmussen; Sisse Rye Ostrowski; Susanne Dam Nielsen
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.